Mirum Pharmaceuticals, Inc. (MIRM) Shareholders’ equity 2020–2025
Mirum Pharmaceuticals, Inc. (MIRM) shareholders’ equity at each fiscal year-end, per SEC filings.
$314.7MFY2025 · since FY2020: $172.1M → $314.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $314.7M | +39.5% |
| FY2024 | $225.6M | -9.3% |
| FY2023 | $248.7M | +75.1% |
| FY2022 | $142.0M | +18.2% |
| FY2021 | $120.2M | -30.1% |
| FY2020 | $172.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice